Physician profile
Kevin Li
NPI 1912427063
$1,261.95
in general payments reported to CMS, 2019-2025
10 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $356 · 2023: $80.15 · 2024: $337 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596 · Travel and Lodging: $125 · Education: $65.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.74 |
| Travel and Lodging | $124.84 |
| Education | $65.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $424.47 | 2024-2025 | Evoque, Pascal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.43 | 2022 | |
| Philips North America LLC | $149.80 | 2025 | Igt Devices Undivided, Igt Devices Systems Undivided |
| Vifor Pharma, INC. | $111.55 | 2024 | Veltassa |
| Regeneron Healthcare Solutions, INC. | $106.23 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.28 | 2022-2023 | Lifevest |
| Pfizer INC. | $87.17 | 2022 | |
| Abbott Laboratories | $39.14 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $27.76 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $15.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.